CRF Health Launches TrialConsent™ 2.0 Platform

June 16, 2017 Jackie Brusch

Next-generation platform takes electronic informed consent to a new, intuitive and interactive level

Plymouth Meeting, PA – 19 June 2017: CRF Health, the leading global provider of patient-centered eSource technology and service solutions for the life sciences industry, launches version 2 of TrialConsent™, offering new enhancements to the industry’s first electronic informed consent solution with a fully embedded design tool.

The solution promotes better comprehension, compliance and retention rates while reducing regulatory risk. TrialConsent™ 2.0 marks a significant advance in electronic informed consent by offering an improved user interface with enhanced navigation for participants and site personnel. Sponsors, Institutional Review Boards, Ethics Committees and research sites also benefit from the improved collaboration offered by the solution and much simplified review process.    

Rachael Wyllie, CEO commented, “CRF Health is committed to simplifying the path to approval, streamlining complex processes and delivering reliable results for superior clinical trial outcomes. The forward-thinking architecture behind TrialConsent 2.0 allows the platform to be fully integrated with an existing eCOA solution or delivered as a stand-alone solution, simplifying and providing consistency, control and flexibility to the informed consent process. Comprehensive reporting enables study teams and ethics committees to monitor the consent status of sites and participants, track and analyze compliance and ultimately make smarter decisions. We firmly believe this advancement represents a step change in the way Informed Consent can be managed throughout its lifecycle.”

For more information on CRF Health's TrialConsent™ solution, please visit www.crfhealth.com.

About CRF Health

CRF Health is the leading provider of patient-centered eSource and telemedicine solutions for the life sciences industry. With experience in more than 800 clinical trials, over 100 languages and across 74 countries, CRF Health’s TrialMax® platform consistently demonstrates the industry’s highest data accuracy, patient and site compliance, and patient retention. Its recent acquisition of mHealth provider Entra Health, has allowed CRF Health to extend the connectivity of its existing technology to now include cloud-based remote patient monitoring, telehealth, data exchange and analytics.

CRF Health’s eSource solutions improve trial engagement by making the patient the center of the healthcare and clinical trial process. The integrated TrialMax platform includes eCOA solutions for collecting PROs (Patient Reported Outcomes), ObsROs (Observer Reported Outcomes), ClinROs (Clinician or Rater Reported Outcomes), and PerfOs (Performance Outcomes), and features TrialConsent™, an electronic solution for collecting informed consent in clinical trials.

Contact:  media@crfhealth.com, +1 267.498.2350

Previous
CRF Health Collaborates with University Hospital Basel to Create Electronic Version of Neurostatus-Expanded Disability Status Scale Form
CRF Health Collaborates with University Hospital Basel to Create Electronic Version of Neurostatus-Expanded Disability Status Scale Form

Next
DIA Global Forum: Are Clinical Trials Ready to Embrace the IoE?
DIA Global Forum: Are Clinical Trials Ready to Embrace the IoE?

Now Available: 5 Best Practices for Using Connected Devices in Clinical Trials

Watch Now